Get the Stockscreener App
0.3901
11.20%
0.0393
Karyopharm Therapeutics Inc Stock (KPTI) Forecast
The Karyopharm Therapeutics Inc (KPTI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $28.13, representing a +7,111% increase from the current price of $0.3901. The highest analyst price target is $52.49, and the lowest is $3.7733.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KPTI Price Target
Average 73.76
(+18,807% Upside)
Is Karyopharm Therapeutics Inc (KPTI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 18.71 | Buy |
| STOCH(9,6) | 6.0287 | Buy |
| STOCHRSI(14) | 46.20 | Neutral |
| MACD(12,26) | -0.4517 | Sell |
| ADX(14) | 61.99 | Sell |
| William %R | -93.91 | Buy |
| CCI(14) | -37.60 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5159
Sell
|
0.5672
Sell
|
| MA20 |
0.9826
Sell
|
0.8834
Sell
|
| MA50 |
1.5071
Sell
|
2.0521
Sell
|
| MA100 |
4.9128
Sell
|
3.7366
Sell
|
| MA200 |
6.3942
Sell
|
5.0204
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, KPTI could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on KPTI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 18.71 indicates that KPTI is oversold. This indicates that KPTI price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 6.0287 indicates that KPTI is oversold. This indicates that KPTI price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.2 indicates that KPTI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 61.99 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -37.6 indicates that KPTI is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term KPTI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Karyopharm Therapeutics Inc financial reports and earnings history, Karyopharm Therapeutics Inc (KPTI) stock could reach $21.73 by 2030, $129.73 by 2040 and $261.09 by 2050. See the projected annual prices until 2050 of the Karyopharm Therapeutics Inc stock below:
- Karyopharm Therapeutics Inc (KPTI) is expected to reach an average price of $64.68 in 2035, with a high prediction of $75.12 and a low estimate of $68.58. This indicates an $16,481% rise from the last recorded price of $0.3901.
- Karyopharm Therapeutics Inc (KPTI) stock is projected to chart a bullish course in 2040, with an average price target of $129.39, representing an $33,067% surge from its current level. The forecast ranges from a conservative $128.68 to a sky-high $129.73.
- Our analysts predict Karyopharm Therapeutics Inc (KPTI) to jump 49,982% by 2045, soaring from $171.55 to an average price of $195.37, potentially reaching $170.97. While $171.55 is the low estimate, the potential upside is significant.
- Karyopharm Therapeutics Inc (KPTI) stock is expected to climb by 2050, reaching an average of $251.83, a $64,455% jump from its current level. However, a wide range of estimates exists, with high and low targets of $261.09 and $263.29, respectively, highlighting the market's uncertainty.
Karyopharm Therapeutics Inc Stock (KPTI) Year by Year Forecast
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2026
The predicted value for Karyopharm Therapeutics Inc (KPTI) in 2026 is set at an average of $26.40. Estimates vary from a peak of $52.49 to a trough of $0.31, indicating an +6,667% surge from the present price of $0.3901.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $27.04 | $3.7733 | $52.49 | +6,830% |
| December, 2026 | $34.10 | $6.9826 | $36.05 | +8,641% |
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Karyopharm Therapeutics Inc (KPTI) is $73.63, with a high forecast of $147.19 and a low forecast of $0.0639. This indicates an +18,774% increase from the last price of $0.3901.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $49.11 | $20.26 | $53.35 | +12,490% |
| February, 2027 | $79.28 | $39.93 | $80.48 | +20,222% |
| March, 2027 | $22.25 | $14.45 | $147.19 | +5,605% |
| April, 2027 | $49.27 | $17.35 | $50.77 | +12,530% |
| May, 2027 | $20.90 | $17.45 | $58.08 | +5,257% |
| June, 2027 | $24.96 | $4.5127 | $27.51 | +6,298% |
| July, 2027 | $9.3736 | $1.4236 | $33.89 | +2,303% |
| August, 2027 | $0.0973 | $0.3223 | $16.25 | -75.07% |
| September, 2027 | $16.27 | $2.8002 | $19.34 | +4,070% |
| October, 2027 | $15.53 | $4.9478 | $23.88 | +3,881% |
| November, 2027 | $8.4586 | $0.0639 | $26.49 | +2,068% |
| December, 2027 | $8.772 | $1.3744 | $20.78 | +2,149% |
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2028
In 2028, Karyopharm Therapeutics Inc (KPTI) is projected to reach an average price of $15.13, with a high projection of $29.60 and a low estimate of $0.6495. This indicates an +3,778% rise from the last price of $0.3901.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $16.25 | $6.8695 | $27.75 | +4,066% |
| February, 2028 | $8.9355 | $6.692 | $20.49 | +2,191% |
| March, 2028 | $11.17 | $11.82 | $7.8722 | +2,764% |
| April, 2028 | $4.5588 | $10.19 | $8.8063 | +1,069% |
| May, 2028 | $5.4796 | $11.78 | $10.40 | +1,305% |
| June, 2028 | $9.3837 | $1.3929 | $14.93 | +2,305% |
| July, 2028 | $17.34 | $0.6495 | $17.90 | +4,344% |
| August, 2028 | $19.87 | $19.10 | $18.79 | +4,995% |
| September, 2028 | $28.11 | $23.46 | $24.96 | +7,106% |
| October, 2028 | $24.83 | $24.35 | $26.34 | +6,265% |
| November, 2028 | $30.37 | $25.80 | $27.52 | +7,685% |
| December, 2028 | $31.25 | $29.95 | $29.60 | +7,912% |
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2029
The 2029 price forecast for Karyopharm Therapeutics Inc Stock (KPTI) is $26.99 on average, with a high prediction of $34.11 and a low estimate of $19.86. This represents an +6,818% increase from the previous price of $0.3901.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $34.81 | $30.27 | $31.13 | +8,824% |
| February, 2029 | $34.41 | $35.06 | $34.11 | +8,721% |
| March, 2029 | $32.15 | $33.22 | $33.90 | +8,141% |
| April, 2029 | $32.56 | $32.10 | $31.77 | +8,246% |
| May, 2029 | $27.06 | $31.10 | $31.67 | +6,836% |
| June, 2029 | $24.19 | $24.87 | $22.21 | +6,102% |
| July, 2029 | $17.61 | $19.86 | $22.20 | +4,415% |
| August, 2029 | $23.30 | $21.25 | $21.20 | +5,873% |
| September, 2029 | $20.89 | $22.09 | $21.38 | +5,254% |
| October, 2029 | $22.18 | $22.27 | $21.82 | +5,585% |
| November, 2029 | $22.39 | $22.81 | $22.57 | +5,641% |
| December, 2029 | $22.14 | $20.81 | $21.67 | +5,576% |
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2030
Karyopharm Therapeutics Inc Stock (KPTI) is expected to reach an average price of $19.04 in 2030, with a high forecast of $21.73 and a low forecast of $16.34. This signifies an +4,780% surge from the last price of $0.3901.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $21.89 | $22.57 | $21.73 | +5,511% |
| February, 2030 | $18.98 | $21.19 | $21.57 | +4,765% |
| March, 2030 | $16.38 | $18.75 | $18.50 | +4,098% |
| April, 2030 | $17.22 | $17.42 | $17.14 | +4,314% |
| May, 2030 | $18.32 | $18.23 | $18.33 | +4,596% |
| June, 2030 | $17.87 | $18.04 | $17.56 | +4,480% |
| July, 2030 | $17.46 | $17.74 | $16.71 | +4,377% |
| August, 2030 | $18.96 | $18.56 | $18.51 | +4,759% |
| September, 2030 | $19.10 | $20.02 | $20.54 | +4,796% |
| October, 2030 | $16.97 | $16.85 | $17.22 | +4,251% |
| November, 2030 | $17.43 | $17.86 | $17.37 | +4,368% |
| December, 2030 | $16.20 | $16.34 | $17.04 | +4,053% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):